Biospecifics Tech Cp (BSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 01-2003 | 01-2002 | 01-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,659 | -3,200 | -2,925 | -257 | -1,469 |
| Depreciation Amortization | 785 | 769 | 637 | 437 | 151 |
| Income taxes - deferred | N/A | N/A | 165 | -28 | 350 |
| Accounts receivable | 146 | 562 | 1,617 | -1,441 | 318 |
| Other Working Capital | 4,079 | 937 | 1,468 | -93 | 1,084 |
| Other Operating Activity | -161 | -617 | -1,687 | 1,486 | 138 |
| Operating Cash Flow | $1,190 | $-1,548 | $-727 | $105 | $572 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -195 | -16 | -52 | -608 | -3,823 |
| Other Investing Activity | 12 | 394 | 91 | 167 | -413 |
| Investing Cash Flow | $-183 | $378 | $39 | $-441 | $-4,235 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 47 | 106 | 1 | 1 | 1 |
| Debt Issued | N/A | 1,575 | 0 | 455 | N/A |
| Common Stock Issued | 65 | 0 | 27 | 7 | N/A |
| Other Financing Activity | -43 | -285 | 0 | 0 | 0 |
| Financing Cash Flow | $69 | $1,397 | $28 | $462 | $1 |
| Exchange Rate Effect | N/A | -9 | -7 | -2 | 11 |
| Beginning Cash Position | 269 | 51 | 693 | 569 | 4,221 |
| End Cash Position | 1,346 | 269 | 26 | 693 | 569 |
| Net Cash Flow | $1,077 | $218 | $-667 | $124 | $-3,652 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,190 | -1,548 | -727 | 105 | 572 |
| Capital Expenditure | -195 | -16 | -52 | -608 | -3,823 |
| Free Cash Flow | 996 | -1,564 | -779 | -503 | -3,251 |